Regeneron weighs overseas price for rare hearing loss gene therapy
Regeneron Pharmaceuticals will make its newly approved gene therapy for a rare, genetic form of hearing loss available for free…
Tag: Regeneron
Regeneron inks drug pricing deal with Trump, will offer hearing-loss therapy for free
U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the…
Regeneron (REGN) Draws Higher Target From TD Cowen
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is included among the 13 Companies that Just Started Paying Dividends. Regeneron (REGN) Draws Higher Target…
Morgan Stanley Sees Policy Risks Receding for Regeneron (REGN)
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is included among the 13 Best Debt Free Dividend Stocks to Buy Now. Morgan Stanley Sees…
Regeneron (REGN) Gains Attention With Successful Phase 3 Garetosmab Trial for Rare Disease
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) ranks among the most undervalued NASDAQ stocks to buy now. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) reported on…
BMO Capital Maintains a Buy on Regeneron Pharmaceuticals (REGN), Sets a $640 PT
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best cheap stocks to buy for beginners. In a report released on…
Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure
Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment,…
Regeneron buys 23andMe for $256m after bankruptcy | Business and Economy
Sale of genetic testing company raises concerns about privacy of 23andMe’s 15 million customers. Regeneron Pharmaceuticals has bought the genetic…
23andMe Is Selling All User Data to Drug Developer Regeneron
Genetic testing startup 23andMe, which filed for bankruptcy earlier this year, announced on Monday that it has agreed to sell…
Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M
Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction. Regeneron…